Loading...
A step-by-step guide to appealing when your insurance denies coverage for a prescribed medication, covering formulary exceptions, step therapy overrides, peer-to-peer reviews, and external appeals.
A step-by-step guide to appealing when your insurance denies coverage for a prescribed medication, covering formulary exceptions, step therapy overrides, peer-to-peer reviews, and external appeals.
Insurance medication denials are designed to be discouraging. The letter arrives dense with jargon, the deadline is buried in a paragraph you have to read three times, and the instructions for filing an appeal reference a form that does not appear on the insurer's website. Most patients give up here. That is exactly what insurers count on.
But a denial is not a final answer. It is the opening position in a structured dispute process — one where roughly half of all appeals result in an overturned decision. The system is built to make you quit, and the single most effective thing you can do is refuse to.
This guide covers every step of appealing a medication denial, from understanding the reason code on your denial letter to exhausting your last avenue of external review. The process matters most for patients facing denials on high-cost medications — GLP-1 receptor agonists, specialty biologics, brand-name drugs — where the insurer's financial incentive to deny is strongest.
Before you can fight a denial, you need the specific reason behind it. Request the denial in writing if you have not already received it. The denial letter or Explanation of Benefits (EOB) should include a reason code or explanation, though the clarity of that explanation varies wildly between insurers.
The most common reasons for medication denials:
Your insurance plan maintains a list of covered medications called a formulary. If your prescribed drug is not on that list, the insurer will deny coverage. This is the most common reason for medication denials and hits newer, brand-name medications hardest.
The insurer requires you to try one or more cheaper medications first before they will cover the prescribed drug. This is sometimes called "fail first" — you must demonstrate that less expensive alternatives did not work before the insurer will approve the one your doctor actually prescribed.
Your doctor needs to submit a prior authorization (PA) request to the insurer before the prescription can be filled. If the prescription was submitted without a PA, or if the PA was not approved, the claim gets denied.
The insurer's medical reviewer has determined the medication is not medically necessary for your specific diagnosis. This often happens when a drug is prescribed for an off-label use or when the insurer's clinical criteria diverge from your doctor's judgment.
The insurer considers the medication experimental or investigational for your condition. This can happen even with FDA-approved drugs if you are being prescribed the medication for a use outside the FDA-approved indications.
Your prescription exceeds the insurer's quantity limits for that medication. Your doctor may have prescribed a higher dose than what the insurer considers standard.
If you received a verbal denial at the pharmacy counter, call your insurance company and request a formal written denial. Under federal law, insurers are required to provide written notice of adverse benefit determinations. This letter should include:
Request the clinical criteria. Most patients skip this step, and it costs them. Ask the insurer for the specific medical policy or clinical guideline they used to deny your medication. Their criteria tell you exactly what arguments and evidence you need to present to win.
One thing worth knowing: appeal deadlines vary by plan, and they are not standardized in any way that benefits the patient. Some plans give you 180 days. Some give you 60. The deadline is in the denial letter, and missing it forfeits your right to appeal. Find it and calendar it immediately.
Your prescribing physician is your most important ally in this process. Contact their office and inform them of the denial. There are several paths forward from here:
If the denial was due to a missing prior authorization, your doctor's office can submit one. Many denials are resolved at this stage. Provide your doctor's office with the denial letter so they know exactly what the insurer requires.
Ask your doctor to write a letter explaining why this specific medication is medically necessary for your condition. The letter should address:
A peer-to-peer review is a phone call between your prescribing physician and the insurer's medical director — the doctor who made the denial decision. During this call, your doctor advocates directly for your treatment plan and addresses clinical concerns in real time.
Peer-to-peer reviews work because:
Some doctors' offices are reluctant because the calls consume schedule time. Most will do it if you ask directly.
If your medication was denied because it is not on the formulary, you can file a formulary exception request — a formal process asking the insurer to cover a non-formulary drug as if it were listed.
To win a formulary exception, you typically need to demonstrate that:
Most insurers have a specific form for formulary exception requests. Finding this form is its own small project — it may be buried in a portal, listed under a name you would not guess, or available only by calling a number that routes you through three departments. Your doctor's office may be familiar with the process, but you may need to track down the form yourself and bring it to them.
If your denial is based on a step therapy requirement, you can request an exception. Federal law and many state laws require insurers to grant step therapy exceptions in certain circumstances:
Document your case thoroughly. If you tried the step therapy drugs previously, gather pharmacy records, medical records, and any documentation of side effects or treatment failure. If the step therapy drugs are contraindicated, get a letter from your doctor explaining why.
If prior authorization, peer-to-peer review, and exception requests have not resolved the issue, file a formal internal appeal.
For standard internal appeals, insurers typically have 30 days to respond for pre-service claims (before you receive the medication) and 60 days for post-service claims. For urgent situations, you can request an expedited appeal with a 72-hour decision timeline.
The internal appeal is worth pursuing even when it feels futile, because completing it is a prerequisite for the more powerful step that follows.
If your internal appeal is denied, you have the right to an external review by an independent third party. This is the most structurally important protection in the appeals process because the reviewer is not employed by or financially connected to your insurance company.
External review matters for medication denials specifically because:
To request external review:
The tradeoff between internal appeal and external review is worth understanding: internal appeals are faster and lower effort, but the insurer is reviewing its own decision. External review takes longer and requires more documentation, but the reviewer has no financial stake in denying you. For expensive medications, external review is almost always worth pursuing if the internal appeal fails.
If you believe your insurer has not followed proper procedures, you can file a complaint with your state's department of insurance. This is not an appeal level, but it applies pressure:
File your complaint online through your state's department of insurance website. Include a clear timeline of events, copies of all correspondence, and a specific statement of what you believe the insurer did wrong.
While pursuing your appeal, investigate backup options to keep your treatment uninterrupted:
Most pharmaceutical companies offer patient assistance programs (PAPs) that provide medications at reduced cost or free to eligible patients. Eligibility is typically based on income and insurance status. Even if you have insurance, you may qualify if your medication is not covered.
For brand-name medications, manufacturers often offer copay cards that reduce your out-of-pocket cost. Websites like GoodRx, RxAssist, and NeedyMeds aggregate discount programs and coupons.
Disease-specific foundations (such as the American Diabetes Association, the Arthritis Foundation, etc.) sometimes offer financial assistance for medications or can connect you with resources.
If you receive care at a 340B-eligible healthcare facility (many community health centers, hospitals, and clinics), you may be able to access medications at significantly reduced prices.
GLP-1 receptor agonists like Ozempic, Wegovy, Mounjaro, and Zepbound are among the most commonly denied medications today due to their high cost. If you are appealing a GLP-1 denial:
Related resources:
This information is educational and does not replace professional medical or legal advice.
Use our comparison tool to evaluate EMR systems side-by-side based on your specialty, practice size, and budget.